Sep 10, 2021 / 05:20PM GMT
Jacob William Hughes - Wells Fargo Securities, LLC, Research Division - Senior Analyst
Great. Thanks, everyone, for joining us. I am Jacob Hughes, Specialty Pharmaceuticals Analyst at Wells Fargo. Next up, we have BioCryst Pharmaceuticals. From the company, I'm very pleased to have President and CEO, Jon Stonehouse.
Investors can e-mail me questions via the platform, and I'll ask them on your behalf. Alternatively, you can e-mail me directly at [email protected].
Jon, I'll hand it over to you to give a little bit of an intro on your progress, and then maybe we can jump into Q&A from there.
Jon P. Stonehouse - BioCryst Pharmaceuticals, Inc. - CEO, President & Executive Director
Sure. Thanks, Jacob, and thanks for inviting us to your health care conference. Let me just make some real quick introductions of who's joining me. We've got Charlie Gayer, our Chief Commercial Officer; Helen Thackray, our Chief R&D Officer; John Bluth, our Chief Communications Officer; and Bill Sheridan, our Chief Medical Officer. And we're all
BioCryst Pharmaceuticals Inc at Wells Fargo Virtual Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers